LEFT CARDIAC REMODELING IN MALE HYPERTENSIVE PATIENTS HAVING A NORMAL OR ALTERED HORMONAL PROFILE

Download full text PDF
Issue: 
12
Year: 
2015

N. Fedorova (1), MD; M. Khabibulina (2), Candidate of Medical Sciences 1 -Sverdlovsk Regional Clinical Hospital One, Yekaterinburg 2 -Ural State Medical University, Yekaterinburg

In hypertensive patients with altered sex hormone levels, the remodeling process was found to occur with a more obvious impairment in the geometry of the left heart than in those with normal sex hormone levels.
Keywords: 
hypertensive disease
left ventricle
left cardiac remodeling
testosterone

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Tunstall-Pedoe H., Kuulasmaa K., Mahonen M. et al. Contribution of trends . in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease // Lancet. – 1999; 353 (9164): 1547–57.
  2. Rosmond R., Wallerius S., Wanger P. et al. A 5-year follow-up study of disease incidence in men with an abnormal hormone pattern // J. Intl. Med. – 2003; 254 (4): 386–90.
  3. Teles A., Carreira M., Alarca~o V. et al. Prevalence, severity, and risk factors for erectile dysfunction in a representative sample of 3,548 portuguese men aged 40 to 69 years attending primary healthcare centers: results of the Portuguese erectile dysfunction study // J. Sex Med. – 2008; 5 (6): 1317–24.
  4. Feldman H., Johannes C., Derby C. et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study // Prev. Med. – 2000; 30 (4): 328–38.
  5. Svartberg J. et al. Waist circumference and testosterone levels in community dwelling men // Eur. J. Endocrinol. – 2004; 19 (7): 63–7.
  6. Yarnell J., Beswick A., Sweetnam P. et al. Endogenous sex hormones and ischaemic heart disease in men. The Caerphilly prospective study // Arterioscler. Thromb. – 1993; 13: 517–20.
  7. Harman S., Metter E., Tobin J. et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men // J. Clin. Endocrinol. Metab. – 2001; 86: 724–31.
  8. Shores M., Matsumoto A., Sloan K. et al. Low serum testosterone and mortality in male veterans // Arch. Intern. Med. – 2006; 166: 1660–5.
  9. Rybakova M.K., Alehin M.N., Mit'kov V.V. Prakticheskoe rukovodstvo po ul'trazvukovoj diagnostike. Ehokardiografija / M.: Vidar-M, 2008; 512 s.
  10. Natsional'nye rekomendatsii OSSN, RKO i RNMOT po diagnostike i lecheniju HSN (4-j peresm.) // Serdechnaja nedostatochnost'. – 2013; 81 (7): 379–472.
  11. Lang R., Bierig M., Devereux R. et al. Recommendations for chamber quantification // Eur. J. Echocardiogr. – 2006; 7: 79–108.
  12. Rebrova O.Ju. Statisticheskij analiz meditsinskih dannyh. Primenenie paketa prikladnyh programm Statistica / M.: Media-Sfera, 2002.
  13. Arinina E.N., Kolosova E.S., Morgunov L.Ju. Kardiovaskuljarnaja pato logija i defitsit androgenov // Terapevt. – 2006; 4: 53–60.
  14. Laaksonen D. et al. Sex hormones, inflammation and the metabolic syndrome: a population-based study // Eur. J. Endocrinol. – 2003; 149 (6): 601–8.
  15. Federman D., Robbins J., Rall J. Effects of methyl testosterone on thyroid function, thyroxine metabolism, and thyroxine-binding protein // J. Clin. Invest. – 1958; 37: 1024–30.
  16. Vasjuk Ju.A, Kozina A.A., Juschuk E.N. i dr. Osobennosti sistolicheskoj funktsii i remodelirovanija u bol'nyh s arterial'noj gipertoniej // Serdechnaja nedostatochnost'. – 2003; 4 (2): 79–80.
  17. Muiesan M., Salvetti M., Monteduro C. et al. Left ventricularconcentric geometry during treatment adversely affects cardiovascular prognosis inhypertensive patients // Hypertension. – 2004; 43: 731–8.
  18. Pavlova O.S. Kliniko-funktsional'nye osobennosti techenija arteri al'noj gipertenzii pri razlichnyh tipah remodelirovanija levogo zheludoch-ka. Avtoref. dis. … kand. med. nauk. Minsk, 2005.
  19. Hozjainova N.Ju., Tsareva V.M. Strukturno-geometricheskoe remodeliro vanie i strukturno-funktsional'naja perestrojka miokarda u bol'nyh arte-rial'noj gipertoniej v zavisimosti ot pola i vozrasta // Ros. kardiol. zhurn. – 2005; 3: 63–8.
  20. Karachentsev A.N., Sergeev P.V. Vazoaktivnye effekty polovyh gormo nov // Probl. endokrinol. – 2001; 43: 45–53.
  21. Devereux R., Savage D., Sachs I. et al. Relation of hemodynamic load to left ventricular hypertrophy and performance in hypertension // J. Am. Cardiol. – 1999; 51: 171–6.
  22. Lorell B., Carabello B. Left ventricular hypertrophy. Pathogenesis, detection, and prognosis // Circulation. – 2000; 102: 470–9.